North America Stem Cell Manufacturing Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2021 –2028 |
 Размер рынка (базовый год) |
USD 11,076.78 Million |
 Размер рынка (прогнозируемый год) |
USD 23,505.08 Million |
 CAGR |
% |
| Основные игроки рынка |
Рынок производства стволовых клеток в Северной Америке, побочные продукты (линии стволовых клеток, инструменты, расходные материалы и наборы), применение (исследовательские и клинические приложения, банки клеток и тканей и другие), конечный пользователь (биотехнологические и фармацевтические компании, научно-исследовательские институты и академические институты, банки клеток и тканей, больницы и хирургические центры и другие), канал сбыта (прямые продажи и сторонние дистрибьюторы), страна (США, Канада и Мексика), тенденции отрасли и прогноз до 2028 года.
Анализ рынка и аналитика: рынок производства стволовых клеток в Северной Америке
Ожидается, что рынок производства стволовых клеток в Северной Америке будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок растет со среднегодовым темпом роста 10,1% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 23 505,08 млн долларов США к 2028 году с 11 076,78 млн долларов США в 2020 году. Рост распространенности рака и трансплантации стволовых клеток, а также рост новых технологических достижений в области трансплантации стволовых клеток, вероятно, станут основными факторами, которые будут стимулировать спрос на рынке в прогнозируемый период.
Стволовые клетки — это сырье для организма, которое может дифференцироваться в различные клетки. Это клетки, из которых генерируются все остальные клетки со специализированными функциями. Терапия стволовыми клетками определяется как лечение заболеваний, которое включает использование любого типа человеческих стволовых клеток, включая эмбриональные стволовые клетки, взрослые стволовые клетки для аллогенной и аутологичной терапии.
Появление исследований стволовых клеток раскрыло терапевтический потенциал стволовых клеток и их производных . Успешное производство стволовых клеток и их производных оказывает положительное влияние на сферу здравоохранения. Эти продукты стволовых клеток используются для восстановления функции поврежденных тканей и органов и для разработки клеточной терапии на основе стволовых клеток для лечения рака, гематологических заболеваний, генетических заболеваний, аутоиммунных и воспалительных заболеваний.
Рост исследований и разработок ключевыми игроками отрасли для разработки инновационных продуктов, поддержка со стороны правительства и растущее принятие стволовых клеток являются движущей силой роста рынка. Передовые методологии, присутствующие в этой области, также стимулируют рост мирового рынка производства стволовых клеток. Однако высокая стоимость терапии, доступность альтернатив для лечения опухолей могут сдерживать рынок. Наличие большого количества продуктов в разработке наряду со стратегическими инициативами, предпринятыми игроками рынка, действуют как возможности для рынка. Нехватка квалифицированных специалистов может выступать в качестве проблемы для рынка.
The global stem cell manufacturing market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Stem Cell Manufacturing Market Scope and Market Size
The stem cell manufacturing market is categorized into four notable segments which are based on products, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of products, stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies
- On the basis of application, cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking and others. In 2021, research applications segment is expected to dominate market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.
- On the basis of end user, stem cell manufacturing market is segmented into biotechnology & pharmaceutical companies, research institutes and academic institutes, cell banks and tissue banks, hospital & surgical centers and others. In 2021, pharmaceutical & biotechnology companies segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.
- On the basis of distribution channel, stem cell manufacturing market is segmented into direct sales and third party distributors. In 2021, direct sales segment is expected to dominate the market because of large number of players in the market.
North America Stem Cell Manufacturing Market Country Level Analysis
The stem cell manufacturing market is analysed and market size information is provided by products, application, end user and distribution channel.
The countries covered in the North Ammerica stem cell manufacturing market report are U.S., Canada, and Mexico.
The U.S. is dominating the global stem cell manufacturing in the North America region due to presence largest consumer market with high GDP, rise in chronic diseases and large number of players presence in the market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Stem Cell Manufacturing Market
The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.
Competitive Landscape and North America Stem Cell Manufacturing Market Share Analysis
North America stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.
The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.
The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.
For instance,
- In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
- В июне 2021 года Catalent Inc. объявила о приобретении RheinCell Therapeuics, производителя человеческих индуцированных плюрипотентных стволовых клеток. Это поможет компании нарастить существующую разработку процесса клеточной терапии на заказ.
- В июне 2021 года компания Bio-Techne объявила, что расширила свои производственные мощности в области генной инженерии, клеточной и генной терапии. Это поможет компании и дальше расширять свой бизнес.
Сотрудничество, совместные предприятия и другие стратегии участников рынка расширяют возможности компании на рынке производства стволовых клеток, что также дает организации возможность улучшить свое предложение на рынке производства стволовых клеток.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA STEM CELL MANUFACTURING MARKET: REGULATIONS
5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
5.2 REGULATORY FRAMEWORK IN EUROPE
5.3 REGULATORY FRAMEWORK IN INDIA
5.4 REGULATORY FRAMEWORK IN JAPAN
6 PESTEL ANALYSIS
7 PORTERS FIVE FORCES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CANCER
8.1.2 INCREASE INVESTMENT IN R & D
8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
8.2 RESTRAINTS
8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
8.3 OPPORTUNITIES
8.3.1 PRESENCE OF PIPELINE PRODUCTS
8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 IMPACT OF COVID-19 ON NORTH AMERICA STEM CELL MANUFACTURING MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY
9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
9.5 CONCLUSION
10 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 CONSUMABLES & KITS
10.2.1 CULTURE MEDIA
10.2.2 DIFFERENTIATION KITS
10.2.3 STEM CELL ANTIBODY ARRAYS
10.2.4 IDENTIFICATION KITS
10.2.5 STEM CELL ANTIBODY PANELS
10.2.6 STEM CELL PRIMER PAIR PANELS
10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
10.2.9 OTHERS
10.3 STEM CELL LINES
10.3.1 HUMAN CELL SYSTEMS
10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
10.3.1.2 MESENCHYMAL STEM CELLS
10.3.1.3 PRIMARY HUMAN CELLS
10.3.1.3.1 FIBROBLAST
10.3.1.3.2 EPITHELIAL
10.3.1.3.3 ENDOTHELIAL
10.3.1.4 HEMATOPOIETIC STEM CELLS
10.3.1.5 NEURAL STEM CELLS
10.3.1.6 CARDIAC STEM CELLS
10.3.1.7 PANCREATIC STEM CELLS
10.3.1.8 OTHERS
10.3.2 RODENT CELL SYSTEMS
10.3.2.1 PLURIPOTENT MOUSE ES CELLS
10.3.2.2 MOUSE EMBRYO CULTURE
10.3.2.3 PMEFS
10.3.2.4 MULTIPOTENT RODENT STEM CELLS
10.3.2.5 MESENCHYMAL STEM CELLS
10.3.2.6 NEURAL STEM CELLS
10.3.2.7 OTHERS
10.4 INSTRUMENTS
10.4.1 BIOREACTORS & INCUBATORS
10.4.2 CELL SORTERS
10.4.3 OTHERS
11 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 RESEARCH APPLICATIONS
11.2.1 LIFE SCIENCE RESEARCH
11.2.2 DRUG DISCOVERY AND DEVELOPMENT
11.3 CLINICAL APPLICATIONS
11.3.1 ALLOGENIC STEM CELL THERAPY
11.3.1.1 SURGERIES
11.3.1.2 MUSCULOSKELETAL DISORDERS
11.3.1.3 WOUNDS AND INJURIES
11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
11.3.1.5 OTHERS
11.3.2 AUTOLOGOUS STEM CELL THERAPY
11.3.2.1 WOUNDS & INJURIES
11.3.2.2 CARDIOVASCULAR DISEASES
11.3.2.3 GASTROINTESTINAL DISEASES
11.3.2.4 OTHERS
11.4 CELL & TISSUE BANKING
11.5 OTHERS
12 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER
12.1 OVERVIEW
12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
12.4 CELL BANKS & TISSUE BANKS
12.5 HOSPITALS & SURGICAL CENTERS
12.6 OTHERS
13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT SALES
13.3 THIRD PARTY DISTRIBUTORS
14 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 AMERICAN CRYOSYSTEM CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 ANTEROGEN.CO.,LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ASTELLAS PHARMA INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 BD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 COMPANY SHARE ANALYSIS
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENT
17.8 BIO-TECHNE
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 CATALENT, INC
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 DAIICHI SANKYO COMPANY, LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 FUJIFILM CELLULAR DYNAMICS, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 COMPANY SHARE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 MESOBLAST LTD
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 ORGANOGENESIS INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 PROMOCELL GMBH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 REPROCELL INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SARTORIUS AG
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 STEMCELL TECHNOLOGIES INC.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 VERICEL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 VIACYTE, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 VISTAGEN THERAPEUTICS, INC.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Список таблиц
LIST OF TABLES
TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:
TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 U.S. STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 47 U.S. CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 48 U.S. STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 49 U.S. HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 50 U.S. PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 51 U.S. RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 52 U.S. INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 53 U.S. STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 U.S. RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 U.S. CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 U.S. ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 U.S. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 U.S. STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 U.S. STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 CANADA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 61 CANADA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 62 CANADA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 63 CANADA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 64 CANADA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 65 CANADA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 66 CANADA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 CANADA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 CANADA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 CANADA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 CANADA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 71 CANADA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 72 CANADA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 CANADA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 MEXICO STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 75 MEXICO CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 76 MEXICO STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 77 MEXICO HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 78 MEXICO PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 79 MEXICO RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 80 MEXICO INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 81 MEXICO STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 MEXICO RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 MEXICO CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 MEXICO ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 MEXICO AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 MEXICO STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
Список рисунков
LIST OF FIGURES
FIGURE 1 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA STEM CELL MANUFACTURING MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
FIGURE 15 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
FIGURE 16 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
FIGURE 17 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 19 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
FIGURE 20 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
FIGURE 21 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2020
FIGURE 24 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
FIGURE 25 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
FIGURE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
FIGURE 29 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
FIGURE 33 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 36 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
